Organovo begins selling 3D printed liver tissue

Another step towards game-changing drug development through synthetic biology.

Gigaom

In case you weren’t sure if we are living in the future, Organovo is here to remind you: The bioprinting company announced today that its 3D printed liver tissue is now commercially available, and pharmaceutical laboratories can begin using it to test if their early-stage drugs are toxic.

The tissue is made from three types of cells found in the human liver. Liver cells need to be arranged in a very precise pattern or they don’t work. That means 3D tissue can give clearer results than the 2D collections of cells that labs currently use because the cells interact and mimic a full liver more convincingly. Organovo said it also makes the drug discovery process faster and, as a result, cheaper.

Organovo prints its liver tissue with a machine that isn’t that far removed from the inkjet printers that can be found on a desktop. Needle-like nozzles lay down the cells in…

View original post 86 more words

Author: Stephan Klaschka

Stephan Klaschka is an awarded innovation executive, C-level consultant, Intrapreneur, and serial entrepreneur with over 25 years of international work experience. He held various senior business operations, strategy, regulatory compliance and innovation roles with Boehringer Ingelheim, leaving as Director of Global Innovation Management and Strategy. In this first-of-its-kind position, Stephan's work was central to the new growth rejuvenation strategy as a catalyst to initiate and drive pivotal innovations, leadership development, and disruptive and digital transformation across the Boehringer Ingelheim group worldwide. He has recently served as CEO interim of the "German Institute for Telemedicine and Health Promotion" (DITG). Stephan holds Masters Degrees in Computer Science, Management, and Business Administration as well as advanced degrees in Strategy, Innovation, and Leadership from leading schools in Europe and the United States. PMP certified. He has published extensively and created award-winning workshops on topics including intrapreneurship, healthcare, pharma, and new technologies. Stephan currently consults independently out of New York.

Please share your thoughts and leave a comment

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s